National Breast Cancer Month Spotlights Awareness Efforts

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 12
Volume 4
Issue 12

WASHINGTON--Zeneca Pharmaceuticals and its National Breast Cancer Awareness Month (NBCAM) co-sponsors have presented First Lady Hillary Rodham Clinton with the Government Leadership Award for her outstanding initiative in launching efforts to educate women about mammography.

WASHINGTON--Zeneca Pharmaceuticals and its National Breast CancerAwareness Month (NBCAM) co-sponsors have presented First LadyHillary Rodham Clinton with the Government Leadership Award forher outstanding initiative in launching efforts to educate womenabout mammography.

Special awards were given to three sets of "partners"who have played pivotal roles in breast cancer awareness: formerFirst Lady Betty Ford and her daughter Susan Ford Bales; NancyBrinker and, posthumously, her sister, Susan G. Komen; and HarveyKushner and, posthumously, his wife, Rose.

Community outreach programs honored were Carilion Health System,Roanoke, Va; Emory University School of Medicine; and HartfordHospital.

Awards for achievement in providing employees access to breastcancer screening and education at the worksite went to MetrolinaOutreach Mammography, Charlotte, NC, and Tri Valley Growers, SanFrancisco.

In the print media category, Oncology Times received an awardfor its stories on the National Surgical Adjuvant Breast and BowelProject.

Primary Care & Cancer, under the editorial directionof James McCarthy and published by PRR, Inc. (which also publishesthe journal Oncology and Oncol-ogy News International), was honoredfor its Breast Self-Examination Guide, and John Gentile, Jr.,president of PRR, won an Awareness Achievement Award (see photographbelow), which he accepted on behalf of the entire staff.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.